Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 SEP 28 ... "This study tested a prediction stemming from the hypothesis that anastrozole users experience heightened vitreo-retinal traction. This hypothesis was based on the ...
2009 JUL 6 ... for ER-positive breast cancer. Antiproliferative effects of the aromatase inhibitor, anastrozole, and Src inhibitor, AZD0530, alone or in combination were tested in vitro and in vivo on ...
2009 SEP 21 ... TX 75219-3931, USA. Keywords: People's Republic of China, Hong Kong, Anastrozole, Aromatase, Breast Cancer, Breast Carcinoma, Convertase, Drugs, Enzyme Research, ...
2009 AUG 10 ... advanced breast cancer, the addition of trastuzumab to the aromatase inhibitor anastrozole, or the tyrosine kinase inhibitor (TKI) lapatinib to letrozole, both have significantly ...
2009 JUL 13 ... discuss in 'Hemicentral retinal artery occlusion in a breast cancer patient using anastrozole' new findings in breast cancer. "Anastrozole, an ...
2009 AUG 3 ... followed by oral administration of doxifluridine and anastrozole, after which no metastasis was detected. About 8 months postoperative, magnetic ...
2009 JUN 29 ... in postmenopausal women, a retrospective study on the effect of aromatase inhibitors (anastrozole or letrozole) was conducted for 16 patients who were not amenable to surgical treatment. ...
2009 MAY 4 ... "The aim of this study was to assess side effects of aromatase inhibitor anastrozole in the prevention of N-methyl-N-nitrosourea - induced pre-menopausal mammary ...
2009 APR 27 ... events. However, the available data suggests a small survival benefit from the use of anastrozole although patients treated with anastrozole appear to ...
2009 JUL 6 ... density (BMD) in Japanese postmenopausal breast cancer patients treated with adjuvant anastrozole were investigated to determine whether there is an ethnic difference from Caucasian ...
2009 MAY 4 ... have reported activity in such patients; therefore, this study formally evaluated anastrozole and exemestane in postmenopausal patients in this setting," scientists writing in the ...
2009 AUG 31 ... "Compared to antiestrogens, third-generation aromatase inhibitors (anastrozole and letrozole) exhibit an improved efficacy and tolerability. Using real-time PCR ...
2009 SEP 28 ... According to a study from Bedford, the United Kingdom, "Prescribing anastrozole instead of tamoxifen increases initial adjuvant drug costs but there is an eventual ...
2009 NOV 2 ... before and after 13-16 weeks of primary medical treatment with the aromatase inhibitors anastrozole or letrozole. mRNA expression of the steroid receptor co-activator 1 (SRC-1) and ...
2009 APR 23 ... medical center. Weinhibited 5 alpha-reduction with dutasteride and aromatization with anastrozole during a pharmacological Te clamp and infused somatostatin (SS), GHRH, GH-releasing ...
2009 JUL 13 ... in the report 'Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.' According to recent research from Istanbul, Turkey, "Metastasis of ...
2009 JUL 27 ... were stimulated with the aromatase substrate, androstenedione, with or without the AI anastrozole (Ana). We found that Ana decreased androstenedione-stimulated growth of wildtype cells, ...
2009 APR 13 ... This study aimed to compare changes in proliferation following 14 days of treatment with anastrozole and letrozole," scientists in Scotland report.
" Two hundred and ...
